Literature DB >> 9163738

Cloning, sequencing, and overexpression of SH2/SH3 adaptor protein Nck from mouse thymus.

D Park1.   

Abstract

Nck, an oncogenic protein containing one SH2 and three SH3 domains, is a common target for phosphorylation by a variety of cell surface receptors. The absence of a recognizable catalytic domain of Nck suggests that Nck serves as a linker molecule to couple cell surface receptors to downstream effector molecules that regulate cellular responses induced by receptor activation. In this study, we isolated Nck cDNA from mouse thymus by screening a phase expression library using monoclonal antibody (mAb) B16-5 which recognizes the SH3 domain of phospholipase C-gamma 1. Nck protein was purified from an extract of the Sf9 cell that had been infected with recombinant baculovirus containing mouse Nck cDNA. The purified protein exhibited an apparent molecular mass of 47 kDa on SDS-polyacrylamide gels. Nck antibody was generated in rabbits using purified protein as an antigen. The distribution of Nck protein in rat tissues examined by immunoblots showed that Nck is expressed widely, and that brain, spleen, and tests contain more Nck than other tissues examined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163738

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  9 in total

1.  Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb.

Authors:  M Chen; H She; A Kim; D T Woodley; W Li
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Essential role of the adaptor protein Nck1 in Jurkat T cell activation and function.

Authors:  I Yiemwattana; J Ngoenkam; P Paensuwan; R Kriangkrai; B Chuenjitkuntaworn; S Pongcharoen
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

3.  The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Authors:  Pankaj Tailor; Sue Tsai; Afshin Shameli; Pau Serra; Jinguo Wang; Stephen Robbins; Masao Nagata; Andrea L Szymczak-Workman; Dario A A Vignali; Pere Santamaria
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

4.  Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways.

Authors:  Y Tu; F Li; C Wu
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

5.  Thymic epithelial requirement for γδ T cell development revealed in the cell ablation transgenic system with TSCOT promoter.

Authors:  Gwanghee Lee; Ki Yeon Kim; Cheong-Hee Chang; Moon Gyo Kim
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

6.  Actin polymerization regulates recruitment of Nck to CD3ε upon T-cell receptor triggering.

Authors:  Piyamaporn Wipa; Pussadee Paensuwan; Jatuporn Ngoenkam; Nadine M Woessner; Susana Minguet; Wolfgang W Schamel; Sutatip Pongcharoen
Journal:  Immunology       Date:  2019-11-26       Impact factor: 7.397

7.  The murine Nck SH2/SH3 adaptors are important for the development of mesoderm-derived embryonic structures and for regulating the cellular actin network.

Authors:  Friedhelm Bladt; Elke Aippersbach; Sigal Gelkop; Geraldine A Strasser; Piers Nash; Anna Tafuri; Frank B Gertler; Tony Pawson
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Expression Analyses Revealed Thymic Stromal Co-Transporter/Slc46A2 Is in Stem Cell Populations and Is a Putative Tumor Suppressor.

Authors:  Ki Yeon Kim; Gwanghee Lee; Minsang Yoon; Eun Hye Cho; Chan-Sik Park; Moon Gyo Kim
Journal:  Mol Cells       Date:  2015-05-27       Impact factor: 5.034

9.  Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation.

Authors:  Jatuporn Ngoenkam; Pussadee Paensuwan; Kanlaya Preechanukul; Boonruang Khamsri; Ichaya Yiemwattana; Esmeralda Beck-García; Susana Minguet; Wolfgang W A Schamel; Sutatip Pongcharoen
Journal:  Cell Commun Signal       Date:  2014-03-26       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.